On May 4, senior researcher of the Bioadaptation laboratory Lala Aydinli held a scientific seminar on “Programmed cell death: to grow or to die?” at the Institute of Molecular Biology and Biotechnologies. The speaker stressed that programmed cell death (PCD) is one of the most intensively studied areas of biology and medicine in modern times. She noted that the reason for this is the cessation of this process due to cancer, aging, diabetes, and a number of neurodegenerative diseases. This genetically controlled process normally helps the body regulate the number of cells and the size of the tissue, as well as protect it from cells that cause homeostasis. In addition, the study of specific enzymes involved in HPO processes can play an important role in the development of sustainable varieties that are beneficial to agriculture. The report aroused great interest among the seminar participants. Lala Aydinli answered the questions.